EQS Equasens Société anonyme

29.01USD26.45 EUR · EPA-1.31%Mkt Cap: 436.03M USDP/E: 9.94

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Servic…

Key Statistics

Company
Market Cap436.03M USD
Enterprise Value449.90M USD
Revenue (TTM)268.77M USD
Gross Profit178.32M USD
Net Income (TTM)43.14M USD
Revenue/Share17.88 USD
Last Price29.01 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.5K
CountryFR
SectorHealthcare
IndustryHealth Information Services
ISINFR0012882389
Valuation
P/E (Trailing)9.94
P/E (Forward)8.13
PEG2.60
EV/EBITDA8.62
EV/Revenue1.67
P/S1.62
P/B1.59
EPS (TTM)2.92 USD
EPS (Forward)3.57 USD
52W Range
28.025% of range49.74
52W High49.74 USD
52W Low28.02 USD
Profitability
Gross Margin68.74%
Oper. Margin20.46%
EBITDA Margin19.42%
Profit Margin16.63%
ROE15.59%
ROA8.96%
ROIC16.05%
ROCE14.84%
Growth
Revenue Growth7.40%
Earnings Growth9.70%
Cash Flow & Leverage
Operating CF64.98M USD
CapEx (TTM)13.23M USD
FCF Margin20.51%
FCF Yield12.64%
Net Debt1.89M USD
Net Debt/EBITDA0.04
Net Debt/FCF0.03
Balance Sheet
Debt/Equity0.24
Current Ratio1.17
Quick Ratio0.85
Book Value/Sh18.24 USD
Cash/Share3.31 USD
Dividends
Fwd Div Rate1.54 USD
Trail. Div Rate1.54 USD
Div. Yield5.08%
5Y Avg Yield1.94%
Payout Ratio48.26%
Ex-Div DateJul 1, 2026
Pay Date—
Splits
Last Split5:1
Split DateAug 5, 2015
Analyst Consensus
Rating—
Target (Mean)56.81 USD
Upside (mean)+95.8%
Target Range45.52 USD – 69.87 USD
45.52+95.8% to mean69.87
# Analysts4
Ownership
Shares Out.15.03M
Float15.00M
Insiders67.09%
Institutions11.37%
Technical
SMA 5031.97 (-9.3%)
SMA 20037.51 (-22.7%)
Beta0.56
S&P 52W Chg12.00%
Avg Vol (30d)21.75K
Avg Vol (10d)17.68K
Technical Indicators
RSI (14)34.4
MACD-0.6087
MACD Signal-0.5690
MACD Hist.-0.0396
BB Upper33.09 USD
BB Middle30.68 USD
BB Lower28.26 USD
BB Width15.75%
ATR (14)0.9218 USD
Vol Ratio (20d)0.59x

About Equasens (EPA: EQS)

›

Equasens (EPA: EQS) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 1,500 employees.

The shares were at 26.45 EUR on 19 November 2026, down 35.9% over 52 weeks. Its 52-week range is 25.55 EUR to 45.35 EUR: the price is 41.7% below the high and 3.5% above the low.

At a market capitalisation of 397.55M EUR, it trades at 9.9 times trailing earnings and 8.1 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 76% for EQS. It pays a dividend yielding 5.08% (it pays out 48% of its earnings).

Equasens reports return on equity of 15.6%, an operating margin of 20.5% and revenue up 7.4% year over year.

Its debt exceeds its cash by 1.72M EUR, a debt-to-equity ratio of 0.24. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 4 analysts cover the stock; their mean price target of 51.80 EUR is 95.8% above the current price. The next earnings report is expected on 1 April 2027.